(Q40370414)

19 September 2017

Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects (English)

1 reference

19 September 2017

1 reference

Bokyung Min

1

1 reference

19 September 2017

Deborah Cios

series ordinal

2

1 reference

19 September 2017

Jeffrey Kluger

series ordinal

3

1 reference

19 September 2017

C Michael White

series ordinal

4

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

19 September 2017

1 reference

19 September 2017

25

1 reference

19 September 2017

12

1 reference

19 September 2017

1719-1724

1 reference

Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine

19 September 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

Electrical storm: case series and review of management

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

Possible association of acute lateral-wall myocardial infarction and bitter orange supplement

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

Dual modulation of a potassium channel by the m1 muscarinic and beta2-adrenergic receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

Exercise-induced syncope associated with QT prolongation and ephedra-free Xenadrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

Baroreflex buffering and susceptibility to vasoactive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

Baroreflex buffering is reduced with age in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

Phenylpropanolamine increases plasma caffeine levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

A pharmacodynamic interaction between caffeine and phenylpropanolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

Effects of caffeine on baroreflex activity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1719

10.1592/PHCO.2005.25.12.1719

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference